Corrigendum to "The relationship between visfatin and metabolic syndrome in postmenopausal women" (Maturitas (2010) 67, (67-71) DOI: 10.1016/j.maturitas.2010.05.002);The relationship between visfatin and metabolic syndrome in postmenopausal women

Maturitas

Volumn 67, Issue 1, 2010, Pages 67-71

  Kim, Jung Ha ^a   Kim, Sang Hwan ^b   Im, Jee Aee ^c   Lee, Duk Chul ^d  

^a Chung Ang University   (South Korea)

^b Eulji University School of Medicine   (South Korea)

^c INTOTO Inc   (South Korea)

^d Yonsei University College of Medicine   (South Korea)

Author keywords

Adipokine; Metabolic syndrome; Postmenopausal women; Visfatin

Indexed keywords

CHOLESTEROL; GLUCOSE; HOMOCYSTEINE; INSULIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TRIACYLGLYCEROL;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BIOCHEMISTRY; BIOLOGICAL ACTIVITY; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTRAABDOMINAL FAT; KOREA; LEUKOCYTE COUNT; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POSTMENOPAUSE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

EID: 77955918010     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2011.03.007     Document Type: Erratum

References (25)

1. H.S. Park, C.Y. Park, S.W. Oh, and H.J. Yoo Prevalence of obesity and metabolic syndrome in Korean adults Obes Rev 9 2 2008 104 107
2. S.E. Shoelson, J. Lee, and A.B. Goldfine Inflammation and insulin resistance J Clin Invest 116 7 2006 1793 1801
3. C.E. Juge-Aubry, E. Henrichot, and C.A. Meier Adipose tissue: a regulator of inflammation Best Pract Res Clin Endocrinol Metab 19 4 2005 547 566
4. B. Samal, Y. Sun, G. Stearns, C. Xie, S. Suggs, and I. McNiece Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor Mol Cell Biol 14 2 1994 1431 1437
5. J.R. Revollo, A. Körner, and K.F. Mills Nampt/PBEF/visfatin regulates insulin secretion in beta cells as a systemic NAD biosynthetic enzyme Cell Metab 6 5 2007 341 343
6. C. Pagano, C. Pilon, and M. Olivieri Reduced plasma visfatin/pre-B cell colony-enhancing factor in obesity is not related to insulin resistance in humans J Clin Endocrinol Metab 91 8 2006 3165 3170
7. D.G. Haider, K. Schindler, G. Schaller, G. Prager, M. Wolzt, and B. Ludvik Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding J Clin Endocrinol Metab 91 4 2006 1578 1581
8. S. Sandeep, K. Velmurugan, R. Deepa, and V. Mohan Serum visfatin in relation to visceral fat, obesity, and type 2 diabetes mellitus in Asian Indians Metabolism 56 4 2007 565 570
9. J. Berndt, N. Klöting, and S. Kralisch Plasma visfatin concentrations and fat depot-specific mRNA expression in humans Diabetes 54 10 2005 2911 2916
10. A. Fukuhara, M. Matsuda, and M. Nishizawa Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430
11. D. Panidis, D. Farmakiotis, and D. Rousso Plasma visfatin levels in normal weight women with polycystic ovary syndrome Eur J Intern Med 19 6 2008 406 412
12. R. Gen, E. Akbay, N. Muslu, K. Sezer, and F. Cayan Plasma visfatin level in lean women with PCOS: relation to proinflammatory markers and insulin resistance Gynecol Endocrinol 25 4 2009 241 245
13. S.M. Grundy, J.I. Cleeman, and S.R. Daniels American Heart Association; National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 17 2005 2735 2752
14. S. Lee, H.S. Park, and S.M. Kim Cut-off points of waist circumference for defining abdominal obesity in the Korea population Korean J Obes 15 2006 1 9
15. A. López-Bermejo, B. Chico-Juli, and M. Fernndez-Balsells Serum visfatin increases with progressive beta-cell deterioration Diabetes 55 10 2006 2871 2875
16. W.X. Jian, T.H. Luo, and Y.Y. Gu The visfatin gene is associated with glucose and lipid metabolism in a Chinese population Diabet Med 23 9 2006 967 973
17. M.P. Chen, F.M. Chung, and D.M. Chang Elevated plasma level of visfatin/pre-B cell colony-enhancing factor in patients with type 2 diabetes mellitus J Clin Endocrinol Metab 91 1 2006 295 299
18. T.D. Filippatos, C.S. Derdemezis, and I.F. Gazi Increased plasma visfatin levels in subjects with the metabolic syndrome Eur J Clin Invest 38 1 2008 71 72
19. M. Zhong, H.W. Tan, H.P. Gong, S.F. Wang, Y. Zhang, and W. Zhang Increased serum visfatin in patients with metabolic syndrome and carotid atherosclerosis Clin Endocrinol 69 6 2008 878 884
20. C.C. Chen, T.C. Li, and C.I. Li The relationship between visfatin levels and anthropometric and metabolic parameters: association with cholesterol levels in women Metabolism 56 9 2007 1216 1220
21. J.H. Kim, G.J. Cho, K.M. Choi, J.H. Han, D.K. Yoon, and S.M. Kim The relationship between plasma visfatin level, obesity and metabolic syndrome in women without diabetes J Korean Soc Study Obes 18 1 2009 15 23
22. L.F. Lu, S.S. Yang, and C.P. Wang Elevated visfatin/pre-B-cell colony-enhancing factor plasma concentration in ischemic stroke J Stroke Cerebrovasc Dis 18 5 2009 354 359
23. J.A. Seo, E.S. Jang, and B.G. Kim Plasma visfatin levels are positively associated with circulating interleukin-6 in apparently healthy Korean women Diabetes Res Clin Pract 79 1 2008 108 111
24. T. Romacho, V. Azcutia, and M. Vázquez-Bella Extracellular PBEF/NAMPT/visfatin activates pro-inflammatory signalling in human vascular smooth muscle cells through nicotinamide phosphoribosyltransferase activity Diabetologia 2009
25. J.R. Revollo, A.A. Grimm, and S. Imai The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells J Biol Chem 279 2004 50754 50763